Why this matters: Three distinct data streams are sending conflicting signals on RTX simultaneously. Options traders hit their most bearish posture in 52 weeks. Short sellers added shares at pace. Yet analysts have spent the past month raising price targets. The divergence is worth watching.
The put-call ratio hit 1.0247 on August 14 — a 52-week high and 3.1 standard deviations above the 20-day mean of 0.94. That reading has since eased to 0.899 as of August 18. The spike was sharp and brief, but it marks the most defensive options positioning RTX has seen all year.
The stock itself rose 1.7% on August 18. It is up 16.5% over the past month. That divergence between options defensiveness and price strength makes the PCR spike harder to read as straightforward conviction.
Short interest stands at 1.41% of free float. It has risen roughly 8.7% over the past month. The week-on-week rate of increase has been elevated. At this absolute level, SI is low. It is not a primary pressure point for the stock.
What is notable is the cost to borrow. It rose 69% in one week to 0.53%. That is a meaningful directional move. The borrow market itself remains very loose — availability is essentially unconstrained, with hundreds of millions of shares still lendable. The CTB spike reflects increased demand from short sellers, not a supply shortage.
The July 23 earnings print moved the stock 9.2% on the day. Five firms raised price targets within 24 hours of that result. RBC Capital moved to $250. Susquehanna went to $245. TD Cowen raised to $240.
Bernstein followed on August 3, lifting its target to $232 from $213 while holding at Market Perform. The consensus mean target now sits at $234.82. RTX closed at $225.49 on August 18, leaving roughly 4.1% implied upside to consensus.
The bull case centers on balanced segment exposure and disciplined capital allocation. The bear case flags stretched valuations — PE sits at 29.3x — and competition in commercial aerospace.
Insider sales clustered around the earnings pop. The Treasurer, a subsidiary President, and a Director all sold shares in late July near prices of $210–$218. Net insider selling totaled roughly $5m over 90 days. Significance scores on each transaction were low (1–3 out of 10), consistent with routine post-earnings window trades rather than a directional signal.
State Street added 2.83 million shares in its most recent filing. JP Morgan Asset Management added 2.71 million. BlackRock added 1.48 million. Institutional holders are broadly building.
Next earnings: October 20.
See the live data behind this article on ORTEX.
Open RTX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
